Benzinga’s News Roundup (TIF, WBD, NVS)
November 25, 2009 10:29 AM
Tiffany & Co. (NYSE: TIF) today provided outlook for financial year 2009. TIF expects EPS for FY09 to be in the range of $1.88 to $1.98 per share while the analysts expect EPS to be $1.77. TIF closed at $41.83 in the previous trading session. TIF is currently trading at $44.28, up 5.86% in the pre-market session.
Wimm-Bill-Dann Foods OJSC (ADR) (NYSE: WBD) today swung to a third quarter profit of $44.5 million as compared to $31 million from the same quarter last year. Total sales declined to $524.1 million as compared to $702.1 million in the year ago period. The gross margin for the third quarter rose to 36% against 33.7% in the year ago period. Yesterday, WBD closed at $19.92. So far in 2009, WBD gained over 200%.
Novartis AG (ADR) (NYSE: NVS) is trading at $55.86, up 1.01% after Idera Pharmaceuticals today announced that Novartis AG will terminate its research collaboration agreement with Idera, with effect from February 21, 2010. In the last six mnoths, NVS gained over 35%.
